FDA clears Myrava’s patient-specific bolus device
September 23, 2026
The device is intended to help clinicians control radiation dose delivery and improve positioning during radiotherapy.
The device is intended to help clinicians control radiation dose delivery and improve positioning during radiotherapy.
NET Recovery’s device applies neurostimulation to quell cravings in individuals with stimulant use disorder.
Clearance marks SystImmune’s first IND enabled by pioneering New Approach Methodologies (NAMs), underscoring global innovation and translational leadership
AKRON, Ohio, Sept. 22, 2026 /PRNewswire/ — Resivant Medical announced today that the U.S. Patent and Trademark Office has issued Patent No. 12,678,148, covering the novel single-lever, single-handed applicator design at the core of the Cutiva™ PLUS Skin Closure System. The patent protects the mechanism that allows clinicians to start, control, and stop the flow of adhesive using a single lever, without repositioning the hand or device.
Pattern Bioscience, an Austin, Texas-based innovator in rapid diagnostic technologies for bacterial infections, has announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for its Urine ID/AST Panel. The panel is the company’s second assay to receive the designation, following the Pneumonia ID/AST Panel, reflecting Pattern’s continued focus on expanding a menu of rapid, direct-from-specimen assays.
Cordis earned FDA approval for its Selution SLR (sustained limus release) drug-eluting balloon (DEB) to treat coronary in-stent restenosis, the device developer announced today.
Composition of matter patent secures exclusive protection for Anixa’s breast cancer vaccine in Australia through 2040, expanding the Company’s growing global IP estate
IDE approval enables initiation of the pivotal Safety in Ovarian Cancer for Average-Risk Women – Analysis (“SOARA”) Clinical Validation Study following Institutional Review Board approval
The approval allows the da Vinci SP system to be utilised in more women’s health procedures across Europe.
NORCROSS, Ga., Sept. 18, 2026 /PRNewswire/ — Koning Health, a global leader in advanced breast imaging technology, today announced that the Koning Breast CT System has been successfully included in the Australian Register of Therapeutic Goods (ARTG), marking an important regulatory milestone for the company’s expansion into the Australian market.